Related Experiment Video
Updated: Jul 16, 2026
Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion
Published on: May 23, 2025
[Treating peritonitis in peritoneal dialysis: guideline from the Italian Society of Nephrology]
V La Milia1, G Virga, M D'Amico
1Italian Society of Nephrology - Italy.
Insights
Intraperitoneal antibiotic administration is the most effective treatment for peritoneal dialysis peritonitis. Intermittent dosing may be preferred over continuous dosing for better outcomes in patients with peritonitis.
Area of Science:
- Nephrology
- Infectious Diseases
- Clinical Guidelines
Context:
- Peritonitis is a common complication in patients undergoing peritoneal dialysis (PD).
- Effective treatment strategies are crucial to prevent morbidity and mortality associated with PD peritonitis.
- This guideline focuses on evidence-based interventions for treating peritonitis in PD patients.
Purpose:
- To summarize evidence from systematic reviews and randomized trials on interventions for treating peritonitis in peritoneal dialysis (PD).
- To provide updated recommendations based on the 3rd edition of the Italian Society of Nephrology guidelines.
Summary:
- Intraperitoneal administration of antibiotics is the most effective treatment for PD peritonitis.
- For Gram-positive bacterial peritonitis, vancomycin or first-generation cephalosporins are recommended.
- For Gram-negative bacterial peritonitis, third-generation cephalosporins or aminoglycosides are suggested.
- A combination of first-generation cephalosporins and Gram-negative agents administered intraperitoneally is a common approach.
- Intermittent antibiotic administration may be preferred over continuous administration.
Impact:
- Provides clinicians with evidence-based recommendations for managing PD peritonitis.
- Aims to improve treatment outcomes and reduce complications associated with PD peritonitis.
- Highlights the importance of intraperitoneal and intermittent antibiotic administration.
Background:
The current 3rd edition of the Italian Society of Nephrology guidelines has been drawn up to summarize evidence of key intervention issues on the basis of systematic reviews (SR) of randomized trials (RCT) or RCT data only. The present guideline reports evidence of interventions to treat peritonitis in peritoneal dialysis (PD).
Methods:
SR of RCT and RCT on treatments for peritoneal dialysis peritonitis were identified referring to a Cochrane Library and Renal Health Library search (2005 update). Quality of SR and RCT was assessed according to current methodological standards.
Results:
Thirty-six RCT were found addressing the intervention issue. Vancomycin or first generation cephalosporins may be used for treating peritoneal dialysis peritonitis due to Gram-positive agents. Third-generation cephalosporins or amino-glycosides may be used for Gram-negative agents peritonitis. Association of first-generation cephalosporins and agents against Gram-negative bacteria via the intraperitoneal route represents the most frequently used approach. Intraperitoneal administration of antibiotic agents is the most effective treatment of peritoneal dialysis peritonitis. Intermittent administration may be preferred to continuous administration of antibiotic agents in peritoneal dialysis peritonitis.
Conclusion:
In peritoneal dialysis peritonitis current evidence supports the hypothesis that intraperitoneal administration of antibiotics agents and intermittent administration may be preferred to other routes of administration and continuous administration. Further studies are necessary to test this hypothesis in selected patient populations.
Related Concept Videos
01:25Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
01:25Peritoneal Dialysis III: Nursing Management
01:30Peritoneal Dialysis I: Introduction and Procedure
01:20Acute Kidney Injury V: Interprofessional Care
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
01:28Acute Pyelonephritis II: Diagnostic Studies and Management